B- and T-cell responses to the mycobacterium surface antigen PstS-1 in the respiratory tract and adjacent tissues - Role of adjuvants and routes of immunization

By Rodrguez A.   Troye-Blomberg M.   Lindroth K.   Ivanyi J.   Singh M.   Fernandez C.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 458-467

Elsevier

Access to resources Recommend Favorite

Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design

By Herrera O.B.   Brett S.   Lechler R.I.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 231-242

Elsevier

Access to resources Recommend Favorite

Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants

By Le T.P.   Church L.W.P.   Corradin G.   Hunter R.L.   Charoenvit Y.   Wang R.   de la Vega P.   Sacci J.   Ballou W.R.   Kolodny N.   Kitov S.   Glenn G.M.   Richards R.L.   Alving C.R.   Hoffman S.L.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 305-312

Elsevier

Access to resources Recommend Favorite

Modulation of the antigen presentation activity in foot and mouth disease virus (FMDV) vaccines by two adjuvants: avridine and a water soluble fraction of Mycobacterium sp.

By Wigdorovitz A.   Zamorano P.   Borca M.V.   Sadir A.M.  

Vaccine, Vol. 16, Iss. 17, 1998-10 ,pp. : 1627-1632

Elsevier

Access to resources Recommend Favorite

Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine

By Koike Y.   Yoo Y.C.   Mitobe M.   Oka T.   Okuma K.   Tono-oka S.   Azuma I.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1982-1989

Elsevier

Access to resources Recommend Favorite